Shennon Biotechnologies

📍 San Francisco, United States🗓 Founded 2021👥 9 employees
Biotechnology Research🌐 shennonbio.com
Website LinkedIn
ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoimmune diseases. Based in San Francisco next to UCSF Mission Bay, we are funded by DCVC, Foundation Capital and AV8. www.shennonbio.com
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Shennon Biotechnologies founded?
Shennon Biotechnologies was founded in 2021.
What industry is Shennon Biotechnologies in?
Shennon Biotechnologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Shennon Biotechnologies based?
Shennon Biotechnologies is headquartered in San Francisco, United States.